http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2069334-B1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_45ccbb3dc9946989a7b896729afb7f41 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D407-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-353 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D407-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 |
| filingDate | 2008-09-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2011-11-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_93114fd79151b81962d426f79f08807d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6f8a5bd6161f0f891d8492cae8495f5e |
| publicationDate | 2011-11-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-2069334-B1 |
| titleOfInvention | Aspalathin-like dihydrochalcone, extracts from unfermented rooibos and process for preparation |
| abstract | The present invention relates to a novel chemical compound of the formula (I) and to pharmaceutically acceptable salts, derivatives and esters thereof. In addition, the invention also relates to a process for isolating the compound of the formula (I) from raw rooibos material. The present invention likewise relates to a rooibos extract which has a content of the compound of the formula (I) of at least 0.4% by weight. The invention further relates to the use of the chemical compound of the formula (I) and to the pharmaceutically acceptable salts, derivatives and esters thereof, and of the inventive rooibos extract as a medicament, especially for treatment of neurological and psychiatric disorders of the central nervous system. The expression “pharmaceutically active” also includes those effects which lead to a subjective improvement in mental state, in which case approval under pharmaceutical legislation need not be absolutely necessary. The compound of the formula (I) is shown below: (formula I). |
| priorityDate | 2007-10-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 171.